Cell Therapy Market Size, Growth Trend Report Analysis 2027

report image

Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Therapy Type (Allogeneic, Autologous); Product (Consumables, Equipment, Systems and Software); Technology (Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, Cell Immortalization Technology, Cell Plasticity Technology, Three-dimensional Technology); Application (Oncology, Cardiovascular, Orthopedic, Wound Management, Other Applications); End User (Research Institutes, Hospitals, Others), and Geography

Publication Month: Jan 2021 | Report Code: TIPRE00009666 | No. of Pages: 201 | Category: Biotechnology | Status: Published

The cell therapy market is expected to reach US$ 12,563.23 million by 2027 from US$ 7,260.50 million in 2019. The market is estimated to grow at a CAGR of 7.2% from 2020–2027.

The growth of the market is attributed to increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and surging number of approvals for cell-based therapies. However, the high cost of cell therapy manufacturing hinders the growth of the cell therapy market

Lucrative Regions for Cell Therapy Market



Lucrative Regions for Cell Therapy Market

Get more information on this report :


Market Insights

Increasing Number of Approvals for Cell-Based Therapies

The advancements in biotechnology have led to the adoption of personalized treatments for a wide range of indications. Stem cell therapies are being used to treat chronic diseases, such as cancer, neurological disorders, and genetic disorders. Further, the advantages of cell therapy such as targeted treatment, faster and efficient recovery, and reduced side effects promote the adoption of various products. In North America, cell therapies are widely adopted owing to the availability of FDA-approved products. For instance, in April 2020, the FDA awarded regenerative medicine advanced therapy designation to Novartis' Kymriah to treat refractory (r/r) follicular lymphoma (FL) in adults. In July 2020, the FDA approved a CAR T-cell therapy brexucabtagene autoleucel (Tecartus) for patients with mantle cell lymphoma. It is the first FDA-approved CAR T-cell therapy for mantle cell lymphoma and it was approved under the Accelerated Approval pathway. Tecartus also received Orphan Drug designation, which encourages the development of drugs for rare diseases. The other approved CAR-T cell therapies for cancer are Kymriah for acute lymphoblastic leukemia and Yescarta for diffuse large B-cell lymphoma. Apart from this, with more than 250 clinical trials worldwide studying CAR T-cell therapies, additional cell therapies are on their way with potential indications including pancreatic cancer, autoimmune diseases, Alzheimer’s, and Parkinson’s disease. This is expected to drive the cell therapy market.

Therapy Type-Based Insights

The cell therapy market, based on therapy type, is bifurcated into allogeneic and autologous. In 2019, the allogeneic segment accounted for a larger share owing to the availability of substantial number of approved products for clinical use. For instance, in 2018, Alofisel developed by TiGenix (Takeda) is the first allogeneic stem cell-based therapy approved for use in Europe.

Cell Therapy Market, by Therapy Type – 2019 and 2027



Cell Therapy Market, by Therapy Type – 2019 and 2027

Get more information on this report :


Product-Based Insights

The cell therapy market, by product, is segmented into consumables, equipment, and systems and software. The consumables segment held the largest share of the market in 2019, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Technology-Based Insights

Based on technology, the cell therapy market is segmented into viral vector technology, genome editing technology, somatic cell technology, cell immortalization technology, cell plasticity technology, and three-dimensional technology. The viral vector technology segment held the largest share of the market in 2019. Also, the same segment is anticipated to register the highest CAGR in the market during 2020–2027.

Application-Based Insights

The cell therapy market, by application, is segmented into oncology, cardiovascular, orthopedic, wound management, and other applications. The oncology segment held the largest share of the market in 2019. Also, the same segment is anticipated to register the highest CAGR in the market during the forecast period.

End User-Based Insights

Based on end user, the cell therapy market is segmented into hospitals, research institutes, and others. The research institutes segment held the largest share of the market in 2019, and it is estimated to register the highest CAGR in the market during the forecast period.

Strategic Insights

Report Coverage - Cell Therapy Market
Report CoverageDetails
Market Size Value inUS$ 7,260.50 Million in 2019
Market Size Value byUS$ 12,563.23 Million by 2027
Growth rateCAGR of 7.2% from 2020-2027
Forecast Period2020-2027
Base Year2020
No. of Pages201
No. of Tables118
No. of Charts & Figures78
Historical data availableYes
Segments coveredTherapy Type ; Product ; Technology ; Application ; End User , and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

A few players operating in the cell therapy market are Vericel Corporation; MEDIPOST; NuVasive, Inc.; Mesoblast Limited; JCR Pharmaceuticals Co. Ltd.; Smith & Nephew; Bristol-Myers Squibb Company; Cells for Cells; Stemedica Cell Technologies, Inc; and Castle Creek Biosciences, Inc. These players are adopting several organic and inorganic strategies to enhance their revenue and market standings. For instance, in November 2019, MEDIPOST started the extension of its GMP manufacturing facility. The facility is anticipated to increase the sales of CARTISTEM and the development of a new pipeline of products.

Cell Therapy Market– by Therapy Type

  • Allogeneic
  • Autologous

Cell Therapy Market– by Product

  • Consumables
  • Equipment
  • Systems and Software

Cell Therapy Market– by Technology

  • Viral Vector Technology
  • Genome Editing Technology
  • Somatic Cell Technology
  • Cell Immortalization Technology
  • Cell Plasticity Technology
  • Three-Dimensional Technology

Cell Therapy Market– by Application

  • Oncology
  • Cardiovascular
  • Orthopedic
  • Wound Management
  • Other Applications

Cell Therapy Market– by End User

  • Research Institutes
  • Hospitals
  • Others

Cell Therapy Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
  • Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
  • South and Central America

    • Brazil
    • Argentina

Company Profiles

  • Vericel Corporation
  • MEDIPOST
  • NuVasive, Inc.
  • Mesoblast Limited
  • JCR Pharmaceuticals Co. Ltd.
  • Smith & Nephew
  • Bristol-Myers Squibb Company
  • Cells for Cells
  • Stemedica Cell Technologies, Inc,
  • Castle Creek Biosciences, Inc.

Frequently Asked Questions

Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient's body. This technology relies on replacing dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, because of their ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy also has applications in the development of regenerative medicines.
The growth of the market is attributed to increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and increasing number of approvals for cell-based therapies. However, the high cost of cell therapy manufacturing hinders the growth of the market.
Global cell therapy market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. The North American region is the largest shareholder and the Asia Pacific is the fastest growing market for cell therapy. The market growth in the North American region is expected due to increasing investment in research activities, and product launches.

The List of Companies - Cell Therapy Market

  1. Vericel Corporation
  2. MEDIPOST
  3. NuVasive, Inc.
  4. Mesoblast Limited
  5. JCR Pharmaceuticals Co. Ltd.
  6. Smith & Nephew
  7. Bristol-Myers Squibb Company
  8. Cells for Cells
  9. Stemedica Cell Technologies, Inc,
  10. Castle Creek Biosciences, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell therapy market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global cell therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00009666
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




christmas_festive_offer

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000 $2700
  • $4550 $4095
  • $6550 $5568
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount